From today scientists will be able to access a vast collection of biomedical research and to submit their own published results for inclusion in a new online resource. Based on a model currently used by the US National Institute of Health, UK PubMed Central (UKPMC) will provide free access to a permanent online archive of peer-reviewed research papers in the medical and life sciences. See: www.ukpmc.ac.uk.
A nine-strong group of UK research funders, led by the Wellcome Trust, awarded the contract to develop UKPMC to a partnership between the British Library, The University of Manchester and the European Bioinformatics Institute (EMBL-EBI) last July.
Members of this group now require that articles describing the results of research they support are made available in UKPMC with the aim of maximising its impact. The UKPMC service will ensure that articles resulting from research paid for by any member of the funding consortium will be freely available, fully searchable and extensively linked to other online resources.
Initially UKPMC mirrors the American PubMed Central database (hosted by the NCBI at NIH). From today, UK scientists will also be able to submit their research outputs for inclusion in UKPMC. Through 2007, and beyond, the partners will develop innovative tools for UKPMC to further support biomedical research. In this way, UKPMC will grow into a unique online resource representing the UK’s biomedical research output.
Richard Boulderstone, Director of e-Strategy and Programmes at the British Library, said: “UK PubMed Central will offer a sophisticated and exciting new means of scholarly communication for biomedical researchers. Building on the complementary strengths that the Library and its partners, the University of Manchester and EMBL-EBI, bring to this project, we expect to create a platform for the development of a whole range of new services for the UK and European biomedical research community.”
Mark Walport, Director of the Wellcome Trust commented: “Medical research is not complete until the results have been communicated. The development of UKPMC provides a great opportunity for this research to be made freely available, and I am very pleased that a first class partnership of the British Library, the University of Manchester, and the European Bioinformatics Institute will be running it.”
He added: “This is only the start, however, and over the next few years the challenge will be to develop UKPMC so that it becomes the destination site of choice for the international biomedical research community and all those who are interested in discovering the results of groundbreaking research first hand.”
The British Library will run the service, promote it to researchers, as well as offering support for those who want to include their research papers in UKPMC. The University of Manchester hosts the service – on servers based at MIMAS (Manchester Information and Associated Services) – and will support the process of engaging with higher-education users. EBI, which is part of the European Molecular Biology Laboratory (EMBL), will contribute its biomedical domain knowledge and state-of-the-art text-mining tools to integrate the research literature with the underlying bioinformatics databases.
The UKPMC funder group consists of: Arthritis Research Campaign, The Biotechnology and Biological Sciences Research Council, The British Heart Foundation, Cancer Research UK, The Association of Medical Research Charities, The Chief Scientist Office of the Scottish Executive Health Department, the Department of Health, The Joint Information Systems Committee, the Medical Research Council and the Wellcome Trust.
Cath Brooksbank PhD | alfa
The balancing act: An enzyme that links endocytosis to membrane recycling
07.12.2016 | National Centre for Biological Sciences
Transforming plant cells from generalists to specialists
07.12.2016 | Duke University
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
07.12.2016 | Health and Medicine
07.12.2016 | Life Sciences
07.12.2016 | Health and Medicine